Global Tuberculosis Community Advisory Board (TB CAB)


The Global Tuberculosis Community Advisory Board (TB CAB) is a group of strong, research-literate community activists from HIV and TB networks in Asia, Europe, Africa, and North and South America. Founded in 2011, the TB CAB acts in an advisory capacity to:

  • product developers and institutions conducting clinical trials of new TB drugs, regimens, diagnostics and vaccines; and
  • provide input on study design, early access, regulatory approval, post marketing, and implementation strategies.

The TB CAB is dedicated to increasing community involvement in TB research and access to tools to fight TB and mobilizing political will.


TB CAB members convene at least once annually for an in-person meeting and hold regular teleconferences. TB CAB members are chosen so as to represent the diverse needs, interests, and concerns of the entire spectrum of the TB and HIV patient community. Due to adequate representation and limited funding available to support TB CAB travel, the TB CAB is not currently accepting new members. For those interested in following the work of the TB CAB and staying up to date on TB issues, please subscribe to the TB Online Weekly Newsletter.

For more details on governance of the TB CAB, please see the Terms of Reference.







  • TB CAB founded
  • developed
  • First meeting held with key TB drug developers in Washington, D.C. (Meeting report)